SODIUM FLUORIDE F-18 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Fluoride F-18, and what generic alternatives are available?
Sodium Fluoride F-18 is a drug marketed by 3d Imaging Drug, Bamf, Biomedcl Res Fdn, Cardinal Health 414, Decatur, Essential Isotopes, Hot Shots Nm Llc, Jubilant Draximage, Kreitchman Pet Ctr, Mcprf, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, The Feinstein Inst, Ucsf Rodiopharm, Uihc Pet Imaging, Univ Tx Md Anderson, and Univ Utah Cyclotron. and is included in twenty-four NDAs.
The generic ingredient in SODIUM FLUORIDE F-18 is sodium fluoride f-18. There are one thousand four hundred and seventy-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sodium fluoride f-18 profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Fluoride F-18
A generic version of SODIUM FLUORIDE F-18 was approved as sodium fluoride f-18 by MCPRF on June 28th, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM FLUORIDE F-18?
- What are the global sales for SODIUM FLUORIDE F-18?
- What is Average Wholesale Price for SODIUM FLUORIDE F-18?
Summary for SODIUM FLUORIDE F-18
US Patents: | 0 |
Applicants: | 23 |
NDAs: | 24 |
Finished Product Suppliers / Packagers: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Clinical Trials: | 121 |
Patent Applications: | 9 |
DailyMed Link: | SODIUM FLUORIDE F-18 at DailyMed |
Recent Clinical Trials for SODIUM FLUORIDE F-18
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The University of Hong Kong | N/A |
Universidade Federal do Para | Phase 3 |
Sun Yat-sen University | Phase 2 |
Pharmacology for SODIUM FLUORIDE F-18
Drug Class | Radioactive Diagnostic Agent |
Mechanism of Action | Radiopharmaceutical Activity |